Literature DB >> 22927308

Poly-gene fusion transcripts and chromothripsis in prostate cancer.

Chunxiao Wu1, Alexander W Wyatt, Andrew McPherson, Dong Lin, Brian J McConeghy, Fan Mo, Robert Shukin, Anna V Lapuk, Steven J M Jones, Yongjun Zhao, Marco A Marra, Martin E Gleave, Stanislav V Volik, Yuzhuo Wang, S Cenk Sahinalp, Colin C Collins.   

Abstract

Complex genome rearrangements are frequently observed in cancer but their impact on tumor molecular biology is largely unknown. Recent studies have identified a new phenomenon involving the simultaneous generation of tens to hundreds of genomic rearrangements, called chromothripsis. To understand the molecular consequences of these events, we sequenced the genomes and transcriptomes of two prostate tumors exhibiting evidence of chromothripsis. We identified several complex fusion transcripts, each containing sequence from three different genes, originating from different parts of the genome. One such poly-gene fusion transcript appeared to be expressed from a chain of small genomic fragments. Furthermore, we detected poly-gene fusion transcripts in the prostate cancer cell line LNCaP, suggesting they may represent a common phenomenon. Finally in one tumor with chromothripsis, we identified multiple mutations in the p53 signaling pathway, expanding on recent work associating aberrant DNA damage response mechanisms with chromothripsis. Overall, our data show that chromothripsis can manifest as massively rearranged transcriptomes. The implication that multigenic changes can give rise to poly-gene fusion transcripts is potentially of great significance to cancer genetics.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22927308     DOI: 10.1002/gcc.21999

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  23 in total

Review 1.  Genomic rearrangements in prostate cancer.

Authors:  Christopher E Barbieri; Mark A Rubin
Journal:  Curr Opin Urol       Date:  2015-01       Impact factor: 2.309

2.  Chromothripsis: breakage-fusion-bridge over and over again.

Authors:  Carlos Oscar Sánchez Sorzano; Alberto Pascual-Montano; Ainhoa Sánchez de Diego; Carlos Martínez-A; Karel H M van Wely
Journal:  Cell Cycle       Date:  2013-06-11       Impact factor: 4.534

Review 3.  [Novel preclinical models and biomarkers for prostate cancer].

Authors:  N Korzeniewski; M Tapia-Laliena; Y Tolstov; S Pahernik; B Hadaschik; M Hohenfellner; S Duensing
Journal:  Urologe A       Date:  2013-09       Impact factor: 0.639

Review 4.  Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2019-07-30

Review 5.  The diverse heterogeneity of molecular alterations in prostate cancer identified through next-generation sequencing.

Authors:  Alexander W Wyatt; Fan Mo; Yuzhuo Wang; Colin C Collins
Journal:  Asian J Androl       Date:  2013-03-18       Impact factor: 3.285

Review 6.  Telomeres and telomerase in prostate cancer development and therapy.

Authors:  Mindy Kim Graham; Alan Meeker
Journal:  Nat Rev Urol       Date:  2017-07-04       Impact factor: 14.432

7.  Chromoanagenesis and cancer: mechanisms and consequences of localized, complex chromosomal rearrangements.

Authors:  Andrew J Holland; Don W Cleveland
Journal:  Nat Med       Date:  2012-11-07       Impact factor: 53.440

8.  Chromoplexy: a new paradigm in genome remodeling and evolution.

Authors:  Kendric Wang; Yuzhuo Wang; Colin C Collins
Journal:  Asian J Androl       Date:  2013-08-26       Impact factor: 3.285

9.  nFuse: discovery of complex genomic rearrangements in cancer using high-throughput sequencing.

Authors:  Andrew McPherson; Chunxiao Wu; Alexander W Wyatt; Sohrab Shah; Colin Collins; S Cenk Sahinalp
Journal:  Genome Res       Date:  2012-06-28       Impact factor: 9.043

10.  Chromothripsis-like patterns are recurring but heterogeneously distributed features in a survey of 22,347 cancer genome screens.

Authors:  Haoyang Cai; Nitin Kumar; Homayoun C Bagheri; Christian von Mering; Mark D Robinson; Michael Baudis
Journal:  BMC Genomics       Date:  2014-01-29       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.